Tenaya Therapeutics (TNYA) Shares Outstanding (2020 - 2026)

Tenaya Therapeutics' Shares Outstanding history runs 7 years deep, the most recent figure standing at $217.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 33.41% year-over-year to $217.0 million; the TTM figure through Mar 2026 stood at $217.0 million (up 33.41% YoY), while the FY2025 annual figure was $216.8 million, up 150.47% from the prior year.
• Shares Outstanding was $217.0 million for Q1 2026 at Tenaya Therapeutics, roughly flat from $216.8 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $217.0 million in Q1 2026 to a low of $41.3 million in Q1 2022.
• Historically, Shares Outstanding has averaged $100.5 million across 5 years, with a median of $78.5 million in 2024.
• Biggest YoY gain for Shares Outstanding was 3283.15% in 2022; the steepest drop was 0.23% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $66.9 million in 2022, then grew by 2.2% to $68.3 million in 2023, then climbed by 26.65% to $86.5 million in 2024, then jumped by 150.47% to $216.8 million in 2025, then gained by 0.11% to $217.0 million in 2026.
• The last three Shares Outstanding figures came in at $217.0 million (Q1 2026), $216.8 million (Q4 2025), and $163.7 million (Q3 2025), per Business Quant data.